Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The Europe specialty generics market size reached US$ 16.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 28.1 Billion by 2027, exhibiting a growth rate (CAGR) of 8.86% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic by nature and life-threatening like hepatitis C, cancer, rheumatoid arthritis, multiple sclerosis, etc. 

Driven by factors such as an increasing aging population, changing lifestyles and a rising prevalence of chronic diseases, healthcare costs in Europe have increased significantly in recent years creating a huge burden on the government, healthcare providers and patients. Specialty generics are playing a major role in the region to reduce this cost burden as they are more cost-effective as compared to their branded versions. Unlike branded speciality drugs, specialty generics don’t require expensive and time-consuming research and development procedures. Additionally, they also don’t incur the same amount of marketing and promotional expenses, resulting in substantially lower costs. In addition to this, the patent expiration of several blockbuster specialty drugs is expected to expire in the coming years creating a positive impact on the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on route of administration, indication and distribution channel.

Breakup by Region:

  • Italy
  • Germany
  • France
  • United Kingdom
  • Spain
  • Rest of Europe


Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others


Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others


Breakup by Distribution Channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies
     

Competitive Landscape:

The leading players in the European specialty generics industry have also been examined in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Route of Administration, Indication, Distribution Channel, Country
Countries Covered Germany, France, United Kingdom, Italy, Spain, Rest of Europe
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the European specialty generics market performed so far and how will it perform in the coming years?
  • What is the breakup of the European specialty generics market based on the region?
  • What has been the impact of COVID-19 on the European specialty generics market?
  • What is the breakup of the European specialty generics market based on the route of administration?
  • What is the breakup of the European specialty generics market based on the indication?
  • What is the breakup of the European specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the European specialty generics industry?    
  • What are the key driving factors and challenges in the European specialty generics market?
  • What is the structure of the European specialty generics industry and who are the key players?
  • What is the degree of competition in the European specialty generics market?

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Global Specialty Generics Market: Introduction

    4.1    What are Specialty Generic Drugs?
    4.2    Types of Specialty Generics
5   Why are Specialty Generics So Lucrative?
6   Global Specialty Generics Market

    6.1    Market Overview
    6.2    Market Performance
    6.3    Market Breakup by Route of Administration
    6.4    Market Breakup by Indication
    6.5    Market Breakup by Distribution Channel
    6.6    Market Breakup by Region
    6.7    Market Forecast
7   Europe Specialty Generics Market
    7.1    Market Overview
    7.2    Market Performance
    7.3    Impact of COVID-19
    7.4    Market Breakup by Route of Administration
    7.5    Market Breakup by Indication
    7.6    Market Breakup by Distribution Channel
    7.7    Market Breakup by Region
    7.8    Market Forecast
    7.9    SWOT Analysis
        7.9.1    Overview
        7.9.2    Strengths
        7.9.3    Weaknesses
        7.9.4    Opportunities
        7.9.5    Threats
    7.10    Value Chain Analysis
    7.11    Porters Five Forces Analysis
        7.11.1    Overview
        7.11.2    Bargaining Power of Buyers
        7.11.3    Bargaining Power of Suppliers
        7.11.4    Degree of Competition
        7.11.5    Threat of New Entrants
        7.11.6    Threat of Substitutes
    7.12    Key Market Drivers and Success Factors
8   Market Breakup by Route of Administration
    8.1    Injectables
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Oral
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Others
        8.3.1    Market Trends
        8.3.2    Market Forecast
9   Market Breakup by Indication
    9.1    Oncology
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Autoimmune Diseases
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Infectious Diseases
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Others
        9.4.1    Market Trends
        9.4.2    Market Forecast
10  Market Breakup by Distribution Channel
    10.1    Retail Pharmacies
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Specialty Pharmacies
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Hospital Pharmacies
        10.3.1    Market Trends
        10.3.2    Market Forecast
11  Market Breakup by Region
    11.1    Italy
        11.1.1    Market Trends
        11.1.2    Market Forecast
    11.2    Germany
        11.2.1    Market Trends
        11.2.2    Market Forecast
    11.3    France
        11.3.1    Market Trends
        11.3.2    Market Forecast
    11.4    United Kingdom
        11.4.1    Market Trends
        11.4.2    Market Forecast
    11.5    Spain
        11.5.1    Market Trends
        11.5.2    Market Forecast
    11.6    Rest of Europe
        11.6.1    Market Trends
        11.6.2    Market Forecast
12  Competitive Landscape
    12.1    Market Structure
    12.2    Key Players
    12.3    Profiles of Key Players

List of Figures

Figure 1: Europe: Specialty Generics Market: Major Drivers and Challenges
Figure 2: Global: Specialty Generics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2021
Figure 4: Global: Specialty Generics Market: Breakup by Indication (in %), 2021
Figure 5: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2021
Figure 6: Global: Specialty Generics Market: Breakup by Region (in %), 2021
Figure 7: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Europe: Specialty Generics Market: Sales Value (in Billion US$), 2016-2021
Figure 9: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2021
Figure 10: Europe: Specialty Generics Market: Breakup by Indication (in %), 2021
Figure 11: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2021
Figure 12: Europe: Specialty Generics Market: Breakup by Region (in %), 2021
Figure 13: Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 14: Europe: Specialty Generics Industry: SWOT Analysis
Figure 15: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 16: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 17: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Million US$), 2016 & 2021
Figure 18: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2016 & 2021
Figure 20: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2016 & 2021
Figure 22: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Europe: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2016 & 2021
Figure 24: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Million US$), 2016 & 2021
Figure 26: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Million US$), 2016 & 2021
Figure 28: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Europe: Specialty Generics Market (Other Indications): Sales Value (in Million US$), 2016 & 2021
Figure 30: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Million US$), 2016 & 2021
Figure 32: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Million US$), 2022-2027
Figure 33: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Million US$), 2016 & 2021
Figure 34: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Million US$), 2022-2027
Figure 35: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Million US$), 2016 & 2021
Figure 36: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2022-2027
Figure 37: Italy: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Germany: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: France: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Spain: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Rest of Europe: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027

List of Tables

Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
Table 2: Europe: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 6: Europe: Specialty Generics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Europe: Specialty Generics Market Structure
Table 8: Europe: Specialty Generics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2699

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links